ORCHESTRA BIOMED

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

#People #Financial #More

ORCHESTRA BIOMED

Social Links:

Twitter

Industry:

Biotechnology Health Care Medical Medical Device

Founded:

2017-01-01

Status:

Active

Contact:

917-254-4900

Email Addresses:

[email protected]

Total Funding:

282.82 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics Content Delivery Network Google Universal Analytics JsDelivr Cloudflare JS CDN JS BootstrapCDN JQuery CDN

Current Advisors List

gary-pruden_image

Gary Pruden Strategic Advisor @ Orchestra BioMed
Advisor
2018-10-01

Current Employees Featured

david-hochman_image

David Hochman
David Hochman Chief Executive Officer and Founder @ Orchestra BioMed
Chief Executive Officer and Founder

darren-sherman_image

Darren Sherman
Darren Sherman President, Chief Operating Officer, Director and Founder @ Orchestra BioMed
President, Chief Operating Officer, Director and Founder

paul-goode_image

Paul Goode
Paul Goode Vice President, Development @ Orchestra BioMed
Vice President, Development
2019-10-01

eric-fain_image

Eric Fain
Eric Fain Director, Board Of Directors @ Orchestra BioMed
Director, Board Of Directors
2018-11-01

michael-kaswan_image

Michael Kaswan
Michael Kaswan Chief Financial Officer @ Orchestra BioMed
Chief Financial Officer
2022-01-01

Founder

darren-sherman_image

Darren Sherman

david-hochman_image

David Hochman

Investors List

avenue-venture_image

Investments List

Date	Company	Article	Money raised
2022-05-17	Vivasure Medical	Orchestra BioMed investment in Series D - Vivasure Medical	23 M USD